Rheumatoid Arthritis

Top Story

Tofacitinib linked to 2-fold greater risk for herpes zoster in RA

Tofacitinib linked to 2-fold greater risk for herpes zoster in RA
January 27, 2020
In the Journals

Less than 40% of patients with high RA disease activity modify treatment

January 23, 2020
Despite treat-to-target recommendations for rheumatoid arthritis, only 38% of patients with high disease activity were offered a treatment change during their most…
Education Lab

Ace the Case: A 63-Year-Old Man With a 1-Week History of Headache and Neck Pain

Healio Rheumatology, January 2020
Learning Objective: Upon successful completion of this educational activity, participants should be better able to identify patients with crowned dens syndrome.
In the Journals

Mental distress highly prevalent among adults with arthritis in Appalachia, southern US

January 16, 2020
Frequent mental distress is commonly reported among adults with arthritis across all 50 states and Washington, D.C., with the highest prevalence reported in the…
More Headlines »
CME

Rheumatic Complications of Cancer Immunotherapy: A New and Emerging Field in Rheumatology

This activity is supported by an educational grant from Bristol-Myers Squibb.

More »
Video
Meeting News

AVERT-2 fails to meet primary endpoint, but data advances the field for RA

November 6, 2018
More »
CME

3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - Best Of!

This activity is supported by educational grants from AbbVie, Inc.; Amgen Inc.; Bristol-Myers Squibb; Genentech, Inc.; GlaxoSmithKline; Lilly USA, LLC; Merck & Co., Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

More »